Seroquel XR (quetiapine) is the first atypical antipsychotic approved for major depressive disorder

Seroquel XR (quetiapine) is the first atypical antipsychotic approved for major depressive disorder in Canada.

It will be used as monotherapy or added to antidepressants...when traditional antidepressants aren't enough.

Expect at least half of patients to show an improvement in depression symptoms with Seroquel.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote